trial

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

NCTId NCT00399334
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 1,607 (actual)
Sponsored by Janssen-Cilag Farmaceutica Ltda.
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
1,607 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2005-06
Primary completion
—
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
antipsychotic medications

Sponsors

Janssen-Cilag Farmaceutica Ltda.Lead Sponsor

Sites

0 total

Facts & assertions

3 sourced
Enrollment
1,607
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
antipsychotic medications
drug
lead_sponsor
Janssen-Cilag Farmaceutica Ltda.
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication